Skip to main content
. 2024 Mar 14;24(1):109–115. doi: 10.1007/s40268-024-00458-6

Table 2.

Case reports about LIT in patients with renal impairment

Study Age Gender Infection Linezolid initial dose Dose reduction Renal function Thrombocytopenia Outcome
Cossu et al., 2014 [5] 72 Woman MRSA pulmonary infection 600 mg b.i.d. Discontinuation CRRT 32*10^9/L Thrombocytes reached normal levels 7 days after discontinuation
Tsuji et al., 2015 [9] 78 Man MRSA mediastinitis 600 mg o.d. 300 mg o.d. 8.6 mL/min/1.73 m2 65*10^9/L Thrombocyte count recovered and infection was successfully treated with linezolid
Taguchi et al., 2013 [11] 87 Woman MRSA 1200 mg/day 600 mg o.d. 30 mL/min 54*10^9/L Decreased dose was well tolerated, no thrombocytopenia occurred
Xiao et al., 2018 [23] 50 Woman MRSA endocarditis 600 mg b.i.d. None 23 mL/min/1.73 m2 12*10^9/L Died from multiple organ failure

b.i.d. bis in die = twice a day, CRRT continuous renal replacement therapy, o.d. omne in die = once a day